1,206
Participants
Start Date
May 31, 2009
Primary Completion Date
March 31, 2011
Study Completion Date
March 31, 2011
Moxifloxacin (Avelox, BAY12-8039)
Patients from the normal praxis routine, treated with Moxifloxacin injection with/without sequential tablet treatment according to the local product information
Many Locations
Lead Sponsor
Bayer
INDUSTRY